CANF logo

Can-Fite BioPharma (CANF) Net Income

Annual Net Income

-$7.63 M
+$2.54 M+24.96%

December 31, 2023

Summary

Performance

1-Year Change

+24.96%

3-Year Change

+47.14%

5-Year Change

-16.18%

15-Year Change

-20.43%

CANF Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

73.49%
CANF annual net profit is higher than 73.49% of companies in Healthcare sector

High & Low

All-time High

-$3.68 M

3-Year Low

-$12.62 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CANF previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 10, 2025
CANF next annual earnings announcement is scheduled for Feb 10, 2025

OtherCANFprofitabilitymetrics:

Annual Net Margin

-1027.46%
CANF annual net profit margin is -1027.46%

Annual Revenue

$743.00 K
CANF annual revenue is $743.00 thousand

Annual Gross Profit

-
CANF annual gross profit value is unknown

Annual EPS

-$3.00
CANF annual earnings per share is -$3.00

Quarterly Net Income

N/A

June 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

CANF Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$898.10 K
CANF quarterly net profit is currently at an all-time high

3-Year Low

-$4.12 M
CANF quarterly net profit is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
CANF previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

Feb 10, 2025
CANF next earnings announcement is scheduled for Feb 10, 2025

OtherCANFprofitabilitymetrics:

Quarterly Net Margin

-
CANF quarterly net profit margin value is unknown

Quarterly Revenue

-
CANF quarterly revenue value is unknown

Quarterly Gross Profit

-
CANF quarterly gross profit value is unknown

Quarterly EPS

-
CANF quarterly earnings per share value is unknown

TTM Net Income

N/A

June 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

CANF TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$969.90 K
CANF TTM net profit is currently at an all-time high

3-Year Low

-$13.17 M
CANF TTM net profit is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
CANF previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

Feb 10, 2025
CANF next earnings announcement is scheduled for Feb 10, 2025

OtherCANFprofitabilitymetrics:

Annual Net Margin

-1027.46%
CANF annual net profit margin is -1027.46%

TTM Revenue

-
CANF TTM revenue value is unknown

TTM Gross Profit

-
CANF TTM gross profit value is unknown

TTM EPS

-
CANF TTM earnings per share value is unknown

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$7.63 M
CANF annual net profit is -$7.63 million

Annual Revenue

$743.00 K
CANF annual revenue is $743.00 thousand

Annual Cost Of Goods Sold

-
CANF annual cost of goods sold value is unknown

Annual Operating Expenses

$8.94 M
CANF annual total operating expenses is $8.94 million

Annual Interest Expense

-
CANF annual interest expense value is unknown

Annual Income Tax

$0.00
CANF annual income tax is $0.00

CANF Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+25.0%--
3 y3 years+47.1%--
5 y5 years-16.2%--

CANF Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+39.5%
5 y5-yearat high+47.1%
alltimeall time-107.6%+47.1%

Can-Fite BioPharma Net Income History

DateAnnualQuarterlyTTM
Dec 2023
-$7.63 M(-25.0%)
-$1.65 M(-6.2%)
-$7.63 M(-15.2%)
Sep 2023
-
-$1.76 M(+5.5%)
-$9.00 M(-7.9%)
Jun 2023
-
-$1.67 M(-34.5%)
-$9.77 M(-5.1%)
Mar 2023
-
-$2.55 M(-15.5%)
-$10.29 M(+1.1%)
Dec 2022
-$10.17 M(-19.4%)
-$3.02 M(+19.4%)
-$10.17 M(-9.7%)
Sep 2022
-
-$2.53 M(+15.4%)
-$11.27 M(-7.2%)
Jun 2022
-
-$2.19 M(-10.0%)
-$12.14 M(-7.8%)
Mar 2022
-
-$2.43 M(-40.9%)
-$13.17 M(+4.4%)
Dec 2021
-$12.62 M(-12.7%)
-$4.12 M(+21.1%)
-$12.62 M(+4.0%)
Sep 2021
-
-$3.40 M(+5.6%)
-$12.13 M(+7.3%)
Jun 2021
-
-$3.22 M(+71.4%)
-$11.30 M(-5.6%)
Mar 2021
-
-$1.88 M(-48.3%)
-$11.98 M(-17.1%)
Dec 2020
-$14.44 M(+14.4%)
-$3.63 M(+41.1%)
-$14.44 M(-7.4%)
Sep 2020
-
-$2.58 M(-33.9%)
-$15.59 M(-2.3%)
Jun 2020
-
-$3.89 M(-10.3%)
-$15.97 M(+5.5%)
Mar 2020
-
-$4.34 M(-9.2%)
-$15.13 M(+19.9%)
Dec 2019
-$12.63 M(+92.1%)
-
-
Dec 2019
-
-$4.78 M(+62.3%)
-$12.63 M(+12.0%)
Sep 2019
-
-$2.95 M(-3.7%)
-$11.27 M(+32.6%)
Jun 2019
-
-$3.06 M(+67.1%)
-$8.50 M(+27.2%)
Mar 2019
-
-$1.83 M(-46.6%)
-$6.68 M(+1.7%)
Dec 2018
-$6.57 M(+3.7%)
-
-
Dec 2018
-
-$3.43 M(+1837.3%)
-$6.57 M(+35.7%)
Sep 2018
-
-$177.00 K(-85.8%)
-$4.84 M(-17.1%)
Jun 2018
-
-$1.24 M(-27.7%)
-$5.84 M(-7.9%)
Mar 2018
-
-$1.72 M(+1.2%)
-$6.34 M(+0.0%)
Dec 2017
-$6.34 M(-23.2%)
-
-
Dec 2017
-
-$1.70 M(+44.6%)
-$6.34 M(-18.3%)
Sep 2017
-
-$1.18 M(-32.6%)
-$7.76 M(-12.0%)
Jun 2017
-
-$1.74 M(+1.5%)
-$8.82 M(+4.4%)
Mar 2017
-
-$1.72 M
-$8.45 M
DateAnnualQuarterlyTTM
Dec 2016
-$8.26 M(+72.1%)
-
-
Dec 2016
-
-$3.12 M(+39.3%)
-$8.26 M(+69.6%)
Sep 2016
-
-$2.24 M(+62.8%)
-$4.87 M(-13.2%)
Jun 2016
-
-$1.37 M(-10.0%)
-$5.61 M(-6.2%)
Mar 2016
-
-$1.53 M(-664.3%)
-$5.98 M(+24.7%)
Dec 2015
-$4.80 M(-21.4%)
-
-
Dec 2015
-
$270.50 K(-109.1%)
-$4.80 M(-28.7%)
Sep 2015
-
-$2.98 M(+70.6%)
-$6.73 M(+43.4%)
Jun 2015
-
-$1.75 M(+408.3%)
-$4.69 M(-0.7%)
Mar 2015
-
-$343.50 K(-79.3%)
-$4.72 M(-22.6%)
Dec 2014
-$6.10 M(-26.9%)
-
-
Dec 2014
-
-$1.66 M(+76.3%)
-$6.10 M(-21.1%)
Sep 2014
-
-$941.60 K(-47.1%)
-$7.73 M(-5.2%)
Jun 2014
-
-$1.78 M(+3.4%)
-$8.16 M(+2.8%)
Mar 2014
-
-$1.72 M(-47.7%)
-$7.94 M(-3.8%)
Dec 2013
-$8.34 M(+49.4%)
-$3.29 M(+140.4%)
-$8.26 M(+21.3%)
Sep 2013
-
-$1.37 M(-12.1%)
-$6.81 M(-3.3%)
Jun 2013
-
-$1.56 M(-23.5%)
-$7.04 M(+5.0%)
Mar 2013
-
-$2.04 M(+10.5%)
-$6.70 M(+18.3%)
Dec 2012
-$5.58 M(-16.5%)
-
-
Dec 2012
-
-$1.84 M(+15.3%)
-$5.67 M(-59.2%)
Sep 2012
-
-$1.60 M(+31.0%)
-$13.87 M(+22.0%)
Jun 2012
-
-$1.22 M(+21.7%)
-$11.37 M(-0.2%)
Mar 2012
-
-$1.00 M(-90.0%)
-$11.39 M(-3.6%)
Dec 2011
-$6.68 M(+81.8%)
-
-
Dec 2011
-
-$10.05 M(-1218.9%)
-$11.82 M(+302.7%)
Sep 2011
-
$898.10 K(-172.5%)
-$2.93 M(-38.9%)
Jun 2011
-
-$1.24 M(-13.2%)
-$4.80 M(+34.8%)
Mar 2011
-
-$1.43 M(+22.2%)
-$3.56 M(+66.8%)
Dec 2010
-$3.68 M
-
-
Dec 2010
-
-$1.17 M(+20.3%)
-$2.14 M(+120.3%)
Sep 2010
-
-$969.90 K
-$969.90 K

FAQ

  • What is Can-Fite BioPharma annual net profit?
  • What is the all time high annual net income for Can-Fite BioPharma?
  • What is Can-Fite BioPharma annual net income year-on-year change?
  • What is the all time high quarterly net income for Can-Fite BioPharma?
  • What is the all time high TTM net income for Can-Fite BioPharma?

What is Can-Fite BioPharma annual net profit?

The current annual net income of CANF is -$7.63 M

What is the all time high annual net income for Can-Fite BioPharma?

Can-Fite BioPharma all-time high annual net profit is -$3.68 M

What is Can-Fite BioPharma annual net income year-on-year change?

Over the past year, CANF annual net profit has changed by +$2.54 M (+24.96%)

What is the all time high quarterly net income for Can-Fite BioPharma?

Can-Fite BioPharma all-time high quarterly net profit is $898.10 K

What is the all time high TTM net income for Can-Fite BioPharma?

Can-Fite BioPharma all-time high TTM net profit is -$969.90 K